prof. dr. C.H. van Gils

prof. dr. C.H. van Gils

Full Professor
prof. dr. C.H. van Gils
  • Julius Center, dept. Epidemiology & Health Economics

Research Programs




Carla van Gils obtained her degree in Biomedical Health Sciences (1994) and her PhD degree in Epidemiology at Nijmegen University (1998). In 1998 she received a fellowship from the Dutch Cancer Society in with which she worked as a visiting scientist at the National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA in 1999 and 2000. From 2001 she works at the Julius Center for Health Sciences and Primary Care. From 2014 - June 2021 Carla van Gils was the coordinator of the Cancer Research program of the Julius Center, management team member of the Epidemiology department and board member of the UMC Utrecht Cancer Research program. In October 2017 she was appointed Professor in Clinical Epidemiology of Cancer. Since June 2021 she combines her professorship with a position as director of the Dutch Cancer Society

Side Activities

  • Director of Dutch Cancer Society (KWF Kankerbestrijding)
  • Chair of Board Gezondheidsfondsen voor Rookvrij (GvRV)
  • Member Sounding Board Oncode-PACT
  • Member of Breast Cancer Working Group European Prospective Investigation into Cancer and Nutrition (EPIC)
  • Consultant Bayer (February 2020 - June 2021, fees paid to UMC Utrecht)


Fellowship and Awards

  1. 2009: Personal grant Dutch Cancer Society project ‘Early detection and prevention of breast cancer in women with dense breasts’
  2. 2009: Senior teacher of the year, Epidemiology department, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht
  3. 2007: Elisabeth Steyn Parvé personal development award (University Medical Center Utrecht). Two-year program to train and coach researchers in reaching academic top positions
  4. 1998: Epidemiological fellowship Dutch Cancer Society (1998) for proposal on gene-environment interactions in the etiology of cancer. This program included research projects in the Netherlands (6 months) and USA (1.5 years). Funding for a fellow (Van Gils, C.H.).

Research Output (299)

Assessing Quantitative Parenchymal Features at Baseline Dynamic Contrast-enhanced MRI and Cancer Occurrence in Women with Extremely Dense Breasts

Wang Hui, van der Velden Bas H.M., Verburg Erik, Bakker Marije F., Pijnappel Ruud M., Veldhuis Wouter B., van Gils Carla H., Gilhuijs Kenneth G.A. Aug 2023, In: Radiology. 308

Impact of the COVID-19 Outbreak—Delayed Referral of Colorectal and Lung Cancer in Primary Care:A National Retrospective Cohort Study

Helsper Charles W., Van Gils Carla H., Van Erp Nicole F., Siepman van den Berg Marinde F.R., Rogouti Omar, Van Asselt Kristel M., Maarsingh Otto R., Muris Jean, Brandenbarg Daan, Siesling Sabine, De Wit Niek J., Grant Matthew P., 25 Feb 2023, In: Cancers. 15

Development and validation of risk calculators for people with "thin" melanomas on their skin to predict the likelihood that their cancer will return:a plain language summary of publication

Sharouni Mary-Ann El, Lo Serigne N, Varey Alexander Hr, Elias Sjoerd G, Witkamp Arjen J, Sigurdsson Vigfús, Suijkerbuijk Karijn Pm, van Diest Paul J, van Gils Carla H, Blokx Willeke Am, Scolyer Richard A, Thompson John F Jan 2023, In: Future Oncology. 19 , p. 97-102 6 p.

Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass:The CISLOW-study protocol

Schaeffers Anouk W M A, Devriese Lot A, van Gils Carla H, Dankbaar Jan Willem, Voortman Jens, de Boer Jan Paul, Slingerland Marije, Hendriks Mathijs P, Smid Ernst J, Frederix Geert W J, de Bree Remco 2023, In: PLoS ONE. 18 13 p.

Association of histological features with laryngeal squamous cell carcinoma recurrences:a population-based study of 1502 patients in the Netherlands

Ruiter Lilian N, van Dijk Boukje A C, Bruggink Annette H, Doornaert Patricia A H, Philippens Marielle E P, de Bree Remco, van Gils Carla H, Willems Stefan M Dec 2022, In: BMC Cancer. 22 , p. 1-10

The Impact of the COVID Pandemic on the Incidence of Presentations with Cancer-Related Symptoms in Primary Care

Grant Matthew P, Helsper Charles W, Stellato Rebecca, van Erp Nicole, van Asselt Kristel M, Slottje Pauline, Muris Jean, Brandenbarg Daan, de Wit Niek J, van Gils Carla H 1 Nov 2022, In: Cancers. 14 , p. 1-12

Validation of Combined Deep Learning Triaging and Computer-Aided Diagnosis in 2901 Breast MRI Examinations From the Second Screening Round of the Dense Tissue and Early Breast Neoplasm Screening Trial

Verburg Erik, van Gils Carla H, van der Velden Bas H M, Bakker Marije F, Pijnappel Ruud M, Veldhuis Wouter B, Gilhuijs Kenneth G A 17 Oct 2022, In: Investigative Radiology. 58 , p. 293-298 6 p.

Circulating anti-Müllerian hormone levels and markers of subclinical cardiovascular disease in middle-aged and older men

Verdiesen Renee M. G., Onland-Moret N. Charlotte, van Gils Carla H., van der Schouw Yvonne T. Sep 2022, In: Maturitas. 163 , p. 38-45 8 p.

Elevated miR-29c-5p Expression in Nipple Aspirate Fluid Is Associated with Extremely High Mammographic Breast Density

Vissers Tessa A C M, Piek Leonie, Patuleia Susana I S, Duinmeijer Aafke J, Bakker Marije F, van der Wall Elsken, van Diest Paul J, van Gils Carla H, Moelans Cathy B 5 Aug 2022, In: Cancers. 14 , p. 1-15

Anti-Müllerian Hormone and Cardiometabolic Disease in Women:A Two-Sample Mendelian Randomization Study

Verdiesen Renée M.G., von Berg Joanna, Said M Abdullah, van der Harst Pim, Mahajan Anubha, van Gils Carla H., van der Schouw Yvonne T., Onland-Moret N. Charlotte 25 Jul 2022, In: Reviews in Cardiovascular Medicine. 23

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht





Practical maakt gebruik van cookies

Deze website maakt gebruik van cookies Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Wij plaatsen zelf ook cookies om onze site te verbeteren.

Lees meer over het cookiebeleid

Akkoord Nee, liever niet